Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo

Psychoneuroendocrinology

Volumn 35, Issue 9, 2010, Pages 1333-1338

  Hill, Matthew N ^a   Karatsoreos, Ilia N ^a   Hillard, Cecilia J ^b   McEwen, Bruce S ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adrenal; Cannabinoid; Corticosterone; FAAH; Limbic; Non genomic

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CORTICOSTERONE; ENDOCANNABINOID; GLUCOCORTICOID; PALMIDROL; PHOSPHOLIPASE D;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE ACTION; HYPOTHALAMUS; IN VIVO STUDY; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; TISSUE LEVEL;

AMYGDALA; ANIMALS; CORTICOSTERONE; ENDOCANNABINOIDS; GLUCOCORTICOIDS; HIPPOCAMPUS; HORMONES; HYPOTHALAMUS; INJECTIONS, SUBCUTANEOUS; LIMBIC SYSTEM; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; UP-REGULATION;

EID: 77956618349     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.03.005     Document Type: Article

References (18)

1. Ahn K., et al. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem. Rev. 2008, 108:1687-1707.
2. Campolongo P., et al. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4888-4893.
3. Coddington E., et al. Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior. Endocrinology 2007, 148:493-500.
4. Cravatt B.F., et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9371-9376.
5. Di S., et al. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci. 2003, 23:4850-4857.
6. Freund T.F., et al. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83:1017-1066.
7. Haller J., et al. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front. Neuroendocrinol. 2008, 29:273-291.
8. Hill M.N., McEwen B.S. Endocannabinoids: The silent partner of glucocorticoids in the synapse. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4579-4580.
9. Karst H., et al. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:19204-19207.
10. Kavushansky A., Richter-Levin G. Effects of stress and corticosterone on activity and plasticity in the amygdala. J. Neurosci. Res. 2006, 84:1580-1587.
11. Malcher-Lopes R., et al. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J. Neurosci. 2006, 26:6643-6650.
12. McEwen B.S. Steroid hormone actions on the brain: when is the genome involved?. Horm. Behav. 1994, 28:396-405.
13. Orchinik M., et al. A corticosteroid receptor in neuronal membranes. Science 1991, 252:1848-1851.
14. Patel S., et al. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. J. Lipid Res. 2005, 46:342-349.
15. Roozendaal B., et al. Adrenal stress hormones, amygdala activation, and memory for emotionally arousing experiences. Prog. Brain Res. 2008, 167:79-97.
16. Simon G.M., Cravatt B.F. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J. Biol. Chem. 2006, 281:26465-26472.
17. Simon G.M., Cravatt B.F. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J. Biol. Chem. 2008, 283:9341-9349.
18. Tasker J.G., et al. Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 2006, 147:5549-5556.